Longeveron Company
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and therapies are aimed at improving healthspan.
Headquarters:
Miami
Number Of Exists:
11-50
Total Funding:
8.99997
Founded Date:
2014
Employee Number:
20
Last Funding Type:
Grant
Investor Type:
For Profit
Investors Number:
3
Technology:
Regenerative Medicine
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Industry:
Cellular therapy